What Opvia does

Opvia Limited, operating commercially as Seal, is a London-based software company that builds an AI-native execution platform for GxP-regulated life sciences organizations. The platform ingests unstructured standard operating procedures (SOPs) — in PDF, Word, or paper-scan form — and converts them into controlled, executable digital workflows with review gates, e-signatures, operator training assignments, audit trails, and validation evidence. Its central AI agent, neil, is state-aware and proposes workflow builds from document clauses, surfaces deviations, compares run histories, and scopes process changes while the underlying system remains live. The product is delivered as a cloud-based SaaS suite comprising six blueprints — Manufacturing Execution System (MES), Quality Management System (QMS), QC LIMS, Tech Transfer, Electronic Lab Notebook (ELN), and Inventory Management — that share a common controlled execution spine.

Seal's technology is differentiated by the 48-hour build process, under which a single customer SOP is turned into a live, validated, controlled workflow with auto-generated validation evidence in two days — a step-change versus the multi-month revalidation cycles typical of legacy GxP stacks. The platform is designed for environments governed by FDA/EMA regulations and incorporates 21 CFR Part 11 compliance concepts, continuous audit trails, and change-control workflows that do not require taking processes offline.

Seal generates revenue through subscription SaaS contracts sold via a high-touch, consultative enterprise sales motion. Pricing is not publicly disclosed; prospects engage through "Talk to an Expert" and "Send us one SOP" calls-to-action, with the 48-hour build functioning simultaneously as a proof of concept and an onboarding mechanism. The company's target market is pharmaceutical, biotech, biologics, diagnostics, and adjacent GxP-adjacent companies — over 50 of which are referenced as customers, including Paradromics, Skye Biologics, Acclinate, Bioventix, MiAlgae, Agilent, Beckman Coulter, Ingenza, and Latitude Pharmaceuticals. Seal is venture-backed, having raised a seed round from Y Combinator and Cur8 Capital in 2020 and a follow-on round led by Liquid 2 Ventures in 2022, and is led by founder and CEO William Moss.

Name

Opvia

Website

https://opvia.io

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Opvia, operating as Seal, is a London-based SaaS company that provides an AI-native GxP execution platform converting SOPs into controlled, validated workflows for pharmaceutical, biotech, and life sciences companies. Its AI agent neil and 48-hour onboarding differentiate it from legacy MES/QMS vendors.

Ownership category

akta.pro rank

Product category

GxP Compliance Software

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11) (HLAGAKAG)

akta.pro secondary industry

OCR, ICR & Intelligent Document Processing (IDP) (BPAAAKAB)

Keywords

• GxP compliance software
• Pharmaceutical manufacturing software
• Quality management system
• Electronic batch records
• Lab execution platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscription: Seal operates as a cloud-based SaaS platform for GxP-regulated companies, likely on a subscription basis. Pricing is not publicly disclosed and requires inquiry. The platform encompasses MES, QMS, LIMS, Tech Transfer, ELN, and Inventory modules under a unified controlled execution system.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Opvia operates "Seal," an AI-native GxP execution platform that converts SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. The platform serves GxP-regulated pharmaceutical, biotech, biologics, and life sciences companies with modular blueprints for manufacturing execution, quality management, QC LIMS, tech transfer, electronic lab notebooks, and inventory management.

Product overview

Seal is an AI-native GxP execution platform that transforms static SOPs into controlled, executable workflows. The core platform uses an AI agent called neil to parse documents and generate workflows with compliance features. The platform offers a modular architecture with specialized blueprints including MES (Manufacturing Execution System), QMS (Quality Management System), QC LIMS, Tech Transfer, ELN (Electronic Lab Notebook), and Inventory Management modules. All modules share a common execution spine with integrated training, approvals, audit trails, and validation evidence.

Differentiator

Problem solved

Functional benefit

Products and services

• Seal AI-native GxP execution platform that transforms SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. First process goes live within 48 hours. Built for GxP-regulated life sciences companies including pharmaceutical, biotech, biologics, and medical device organizations. Modular blueprints cover MES, QMS, QC LIMS, Tech Transfer, ELN, and Inventory Management.
• neil State-aware AI execution agent within the Seal platform that reads SOPs (PDF, Word, or paper scans), proposes workflow builds, scopes changes, identifies missing checks, compares run history, simulates next changes, and routes approvals through the controlled system.

Quantifiable outcome

• 90% less time on traveler review
• +5 more outcomes

Named customers9 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Veeva Systems: Dominant life sciences cloud platform with Veeva Vault covering quality, regulatory, and clinical documents. Directly competes with Seal in the GxP/QMS layer but serves a much broader portfolio across pharma.
• LabWare: Established LIMS and laboratory informatics vendor used across pharma, biotech, and applied markets. Directly competes with Seal's QC LIMS blueprint and shares GxP validation requirements.

Direct peers

• MasterControl: Long-standing GxP quality and manufacturing execution platform used by pharma/biotech/medical device companies. Directly competes with Seal's QMS and MES modules for the same regulated customer base.
• Dot Compliance: AI-enabled QMS and quality management for life sciences on Salesforce. Competes with Seal in digitizing SOPs and quality workflows under GxP, with a similar focus on modern UX and faster deployment.
• Kneat (Smart Pharma): Electronic validation and process execution software purpose-built for GxP-regulated life sciences. Directly comparable to Seal's validation evidence generation and controlled workflow capabilities.
• Qualio: Cloud QMS designed for life sciences startups and mid-market pharma/biotech. Competes with Seal's QMS blueprint for the same early-to-mid-stage GxP customer segment.

Emerging players

• Greenlight Guru: QMS platform purpose-built for medical device companies under FDA/ISO 13485. Comparable to Seal in modern UX and vertical specialization, but narrower scope (medical devices only).
• QT9 Software: Cloud QMS with life sciences and manufacturing modules. Competes for the same mid-market GxP customer base as Seal, though with a more traditional QMS-only positioning.
• SimplerQMS: Cloud QMS designed for pharma, biotech, and medical device companies under GxP and 21 CFR Part 11. Directly comparable to Seal's QMS module with a similar compliance-led value proposition.
• Tulip: Frontline operations and manufacturing execution platform increasingly adopted in life sciences. Comparable to Seal's MES blueprint and shared emphasis on connected operator workflows and real-time data capture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/opvia-bio

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Opvia